By Jessie Hellmann Prescription drug companies and trade groups shelled out millions of dollars to lobby Congress as it considered legislation aimed at reining in skyrocketing drug prices, according to new lobbying disclosure reports. The Pharmaceutical Research and Manufacturers of America (PhRMA) — the trade group representing branded drug companies — spent $6.2 million on […]
The American patent system has, since our nation’s founding, served as a cornerstone of innovation.
Lobbying organizations, companies—and individuals—can and do donate money to political campaigns.
Prices for the majority of drugs in the U.S. have started to rise more slowly, likely a result of public and political pressure.
The pharmaceutical industry has outdone itself. It is now the most widely hated industry in the US, unseating the federal government as the lowest of the low, according to a new Gallup poll.
The American people are demanding that Congress hold Big Pharma accountable and the momentum to lower prescription drug prices has never been greater.
U.S. Senator Richard Blumenthal of Connecticut introduced legislation that he hopes will bring down the high cost of prescription drugs.
Despite public and political pressure, pharma keeps on ratcheting up prices.
Prescription drug prices jumped 10.5 percent over the past six months, more slowly than during the same period last year but still four times faster than inflation.
Price hikes on prescription drugs are surging in 2019, despite vows from lawmakers and the Trump administration to rein in pharmaceutical costs.